-+ 0.00%
-+ 0.00%
-+ 0.00%

Novartis Receives CHMP Opinion For Cosentyx In Adolescents Aged 12+ With Hidradenitis Suppurativa

Benzinga·11/13/2026 18:48:10
Listen to the news